11 July 2018
Company Announcements Office Australian Securities Exchange 20 Bridge Street
SYDNEY NSW 2000
Dear Sir/Madam
NOTICE UNDER SECTION 708A OF THE CORPORATIONS ACT
This notice is given by Cynata Therapeutics Limited pursuant to section 708A(5)(e) of the Corporations Act (Act).
The Company has today issued 477,373 fully paid ordinary shares (Shares) following the cashless exercise of 750,000 unlisted 16 December 2018 options.
Pursuant to section 708A(5)(e) of the Act, the Company gives notice that:
1. the Company issued the Shares without disclosure to investors under part 6D.2 of the Act;
2. as at the date of this notice, the Company has complied with:
(a) the provisions of Chapter 2M of the Act as they apply to the Company; and
(b) section 674 of the Act; and
3. as at the date of this notice, there is no information that is "excluded information" (as defined in section 708A(7) of the Act) which is required to be disclosed by the Company.
Yours faithfully
Peter Webse Company Secretary
Cynata Therapeutics Limited
Level 3, 62 Lygon Street, Carlton, Victoria 3053, Australia
PO Box 7165, Hawthorn North, Victoria 3122
T: + 613 9824 5254 F: + 613 9822 7735 E:admin@cynata.com
ABN - 98 104 037 372
Attachments
- Original document
- Permalink
Disclaimer
Cynata Therapeutics Ltd. published this content on 11 July 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 July 2018 09:08:08 UTC